Cannabis Law Report

FEBRUARY 5, 2022

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Communicate with regulatory bodies and global team.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

MMJ Recs

DECEMBER 17, 2023

These dispensaries operate under strict regulations to ensure compliance with the TCUP guidelines. However, MMJ cultivation is subject to strict regulations and oversight by state authorities to ensure compliance with the law. Cultivation for personal use or unauthorized purposes is considered a criminal offense.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

DECEMBER 15, 2021

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Communicate with regulatory bodies and global team.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Veriheal

JULY 16, 2020

Bureaucracy and Compliance Limit The Ability to Conduct Swift and Proper Research . federal government’s policies have blocked externally valid, randomized clinical trials on the effects of cannabis,” the report says. are already using cannabis in compliance with state laws to treat a host of mental health conditions.

Research and Development 95

Research and Development Clinical Trials Treatment Compliance 95

Cannabis Law Report

JANUARY 14, 2022

The primary sticking block on the Government benches is the need for evidence of cannabis efficacy and, to this end, it is urging drug manufacturers to put forward their cannabis medicines for clinical trials.

Access 52

Access Clinical Trials Patients Cannabis 52

Cannabis Law Report

JANUARY 12, 2022

“We can now concentrate all our energies on advancing our plant-inspired, biopharmaceutical research and development programs into human clinical trials.” Following the required transfer of Gb Sciences’ cannabis production and extraction licenses to AJE Management, LLC by the Nevada Cannabis Compliance Board on Dec.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

MAY 29, 2022

Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 28, 2021

The individual in this position supports global regulatory programs, projects, and compliance initiatives across regions and business units. Preference for background in biological or data science (such as: Computer Science, Neuroscience, Cognitive Sciences, Data Science, or a similar field) with a strong interesting in clinical research.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105

Cannabis Law Report

OCTOBER 10, 2021

Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). Manage compliance to global, regional and local processes, policies, SOPs and working instructions. YOUR PROFILE: Bachelor’s degree in life science, relevant scientific field required (e.g.

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

Cannabis Law Report

AUGUST 17, 2021

Most of the Mobile Medical Applications in Clinical Trials are Monitoring Symptoms that can Support Early Disease Diagnosis. Inhaled Vaccines, Cannabis, and Gene Therapy are the Innovative Applications under Research and Clinical Trial. The Strategic Imperative: Factors Creating Pressure on Growth. Research Scope.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

JUNE 20, 2021

LeafCann ’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production, and GMP manufacturing.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit. Key Responsibilities.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Canna Law Blog

JANUARY 3, 2023

And the decision is an important one because, among other things, it will likely inform us all whether or not CBD can be used safely (according to the FDA) in food and supplements; or whether it must be treated as a drug (and, therefore, go through clinical trials for lawful use).

CBD 75

CBD Food Clinical Trials Pets 75

Cannabis Law Report

DECEMBER 9, 2021

There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including history of negative cash flows; limited operating history; incurrence of future losses; availability of additional capital; lack of product revenue; (..)

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

JANUARY 19, 2022

GMP psilocybin previously manufactured by Psygen personnel in collaboration with a licensed dealer using Psygen’s methods has already been used in clinical trials for development of therapeutic products. “A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

JANUARY 24, 2022

Accomplished leader to oversee Goldfinch Bio’s clinical function to advance precision medicines for people living with kidney disease. Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. CAMBRIDGE, Mass.–(BUSINESS

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Legislation is pending, House Bill 625, to establish an industrial hemp pilot program to be in compliance with the new federal hemp regulations. MS resident? Washington. WA resident?

Legislation 160

Legislation Decriminalization Access Therapy 160

Cannabis Law Report

MARCH 16, 2022

of the authorized clinical trials with cannabinoids and about the doubts that currently exist.

Clinical Trials 52

Clinical Trials Chronic Pain Medicine Cannabinoids 52

Cannabis Law Report

JUNE 2, 2021

The Company is offering pooled surveillance testing in compliance with current CDC, FDA, and CMS guidances. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. Food and Drug Administration (U.S.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Cannabis Law Report

AUGUST 21, 2019

In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. The final guideline is expected to be published in November 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

AUGUST 19, 2021

Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed. ” Despite those concerns, Joe Oliver, head of British-based cannabidiol firm LDN CBD, says his products help those with chronic illness.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Cannabis Law Report

JULY 14, 2021

ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

MARCH 29, 2022

Most recently Director of Compliance at the University of Pennsylvania’s Perelman School of Medicine, Dawn previously held senior Quality Assurance roles over the course of two decades at Merck. She will lead the company’s engagement with the medical community through publications, conferences, real-world evidence generation and other means.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

JULY 23, 2019

LGC and its investors will benefit from a substantial competitive advantage through their knowledge and clinical trial capacity and its capacity to handle the regulatory compliance process for pharmaceuticals and food products,” said Mazen Haddad, CEO of LGC.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Cannabis Law Report

NOVEMBER 29, 2019

Lack of clinical trials is a major reason why doctors are cautious about the drug. “Our main priority is informing national and EU institutions about the opportunity that this treatment is offering,” said Sita Schubert, secretary general of EUMCA.

Medicine 59

Medicine Clinical Trials Treatment Access 59

Cannabis Law Report

DECEMBER 7, 2021

The funding enables the company, whilst it continues to maintain focus on strict cost controls, to tailor the timing and size of each capital call to support its ongoing research through clinical trials, its growth, customer engagements, operating costs and planned manufacturing as well as the export of medicinal cannabis into the European Market, (..)

Clinical Trials 52

Clinical Trials Medicine Cannabis Pharmaceutical 52

Cannabis Law Report

MARCH 7, 2019

Switzerland’s government will allow 5,000 citizens to use cannabis legally, as part of a country-wide clinical trial. Those who sign up to the trial would receive a small amount of cannabis each month, to smoke or eat.

Clinical Trials 56

Clinical Trials Research and Development Decriminalization Environment 56

Cannabis Law Report

MARCH 2, 2020

The Department of Health and Social Care continues to work closely with NHS England-NHS Improvement (NHSE-I) and the National Institute of Health Research (NIHR) to establish clinical trials to develop the evidence-base to support further commissioning decisions.

Medicine 59

Medicine Research and Development Clinical Trials Patients 59

Cannabis Law Report

JUNE 9, 2022

Permission to use facilities and premises intended for the circulation of narcotic drugs, psychotropic substances and precursors is issued on the basis of the results of verification of compliance of these facilities and premises with the requirements established by the Ministry of Internal Affairs of Ukraine.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Veriheal

OCTOBER 13, 2020

Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance. More research and clinical trials are needed to fully understand how cannabinoids help those suffering from GI pathologies.

Digestion 123

Digestion Treatment Conditions Research and Development 123

Cannabis Law Report

SEPTEMBER 8, 2021

EPN’s facility is capable of product development, manufacturing, and commercialization of cannabis consumer packaged goods in addition to the manufacture of products and formulations for use in clinical trials to a TGA and EU GMP standard. regulatory risk, U.S.

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. Also, alone it won’t create the “high” sensation associated with the use of Tetrahydrocannabinol or THC. CBD oil or hemp oil has become commonly known in Ireland anecdotally for its possible health benefits.

THC 105

THC CBD Legalization Oil 105

MMJ Recs

DECEMBER 22, 2023

Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana. The scientific community’s growing body of evidence supporting the medical use of cannabis has contributed to a more informed public.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

SEPTEMBER 3, 2019

We are dedicated to making our compliance regimen second-to-none in Australia just as it is in Canada,” said Mr. McCutcheon. Sales generation from the facility is expected to begin in the first half of 2020, subject to receipt of certain local authorizations and a certification from the Therapeutic Goods Association of Australia. “We

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

OCTOBER 15, 2021

Solutech™ is one of the fastest-acting, most bioavailable and comprehensively studied delivery systems for cannabinoids, including THC and CBD, uniquely differentiated for relative oral bioavailability and absorption by a Phase I human clinical trial.

Seed-To-Sale 52

Seed-To-Sale Cultivation Clinical Trials Cannabinoids 52